Alcon has announced the acquisition of STAAR Surgical Company. According to the company announcement Alcon is a global leader in eye care, dedicated to enhancing sight and improving lives through its broad portfolio of products. The company operates in two primary segments: Surgical and Vision Care, offering solutions for conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. Alcon’s products reach over 260 million people in more than 140 countries annually. With a heritage spanning over 75 years, Alcon is committed to innovation, partnerships with Eye Care Professionals, and programs that advance access to quality eye care. In a notable development, Alcon has agreed to acquire STAAR Surgical Company, a leader in refractive surgery known for its Implantable Collamer Lens (ICL) technology, including the EVO family of lenses for myopia correction. This acquisition is expected to complement Alcon’s existing laser vision correction business and broaden its offerings across the full spectrum of myopia treatment.

To learn more about Alcon, visit https://www.alcon.com
Company LinkedIn Page: https://www.linkedin.com/company/alcon/

Company Contact:

Alcon
6201 South Freeway Fort Worth, TX 76134
817-293-0450

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.